Screening high-risk patients early may be the way to go
Researchers suspect that mutations may be leukemogenic
A paradigm-changing collaborator, innovator and leader
Multidisciplinary team approach is critical in HNC care
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study confirms radiotherapy, rituximab as most effective
Advances in technology improve outcomes
For physicians, do patients or family come first?
Time to revisit rigid rules of medicine?
Two global research projects target screening & treatment methods
Transplant-related mortality, relapse rates are low
Advertisement
Advertisement